tiprankstipranks
Advertisement
Advertisement

Haoxi Health Ends Newly Launched $80 Million ATM Share Sales Deal

Story Highlights
  • Haoxi Health had an effective SEC shelf to issue Class A shares in U.S. markets.
  • The company mutually terminated its new $80 million ATM sales deal on February 7, 2026, without selling any shares.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Haoxi Health Ends Newly Launched $80 Million ATM Share Sales Deal

Meet Samuel – Your Personal Investing Prophet

Haoxi Health Technology Limited Class A ( (HAO) ) has provided an update.

Haoxi Health Technology Limited, a Cayman Islands company headquartered in Beijing and listed in the U.S. as a foreign private issuer, has the capacity to raise equity capital through offerings of its Class A ordinary shares registered with the SEC. Its securities are qualified for issuance under an effective Form F-3 shelf registration statement, allowing it to tap U.S. investors when market conditions are favorable.

On January 23, 2026, Haoxi entered into a sales agreement with Aegis Capital Corp. to establish an at-the-market equity program of up to $80 million in Class A ordinary shares, but this arrangement was short-lived. On February 7, 2026, the company and Aegis mutually agreed to terminate the agreement, effective the same day, and no shares were sold under the program, signaling no immediate equity dilution for existing shareholders.

The most recent analyst rating on (HAO) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Haoxi Health Technology Limited Class A stock, see the HAO Stock Forecast page.

Spark’s Take on HAO Stock

According to Spark, TipRanks’ AI Analyst, HAO is a Neutral.

The overall score reflects a combination of strong valuation, with the stock appearing undervalued, and moderate financial performance, highlighted by revenue growth but hampered by cash flow issues. Technical analysis indicates a lack of strong momentum, contributing to the overall risk profile.

To see Spark’s full report on HAO stock, click here.

More about Haoxi Health Technology Limited Class A

Haoxi Health Technology Limited is a Cayman Islands-incorporated company based in Beijing, China. The company is listed in the United States as a foreign private issuer and has the ability to issue Class A ordinary shares on U.S. capital markets under an effective shelf registration.

Average Trading Volume: 30,637

Technical Sentiment Signal: Sell

Current Market Cap: $65.39M

See more data about HAO stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1